

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.37128781 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.37128781 |
| 3 | protein localization to endosome (GO:0036010) | 4.16858001 |
| 4 | barbed-end actin filament capping (GO:0051016) | 3.82092573 |
| 5 | regulation of early endosome to late endosome transport (GO:2000641) | 3.78046892 |
| 6 | stress fiber assembly (GO:0043149) | 3.41560942 |
| 7 | skin morphogenesis (GO:0043589) | 3.40776345 |
| 8 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.17884715 |
| 9 | response to peptidoglycan (GO:0032494) | 3.10691060 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02878510 |
| 11 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98201946 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.95459600 |
| 13 | glycosphingolipid catabolic process (GO:0046479) | 2.93135592 |
| 14 | virion attachment to host cell (GO:0019062) | 2.92015928 |
| 15 | adhesion of symbiont to host cell (GO:0044650) | 2.92015928 |
| 16 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.90864770 |
| 17 | adhesion of symbiont to host (GO:0044406) | 2.87290435 |
| 18 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.87157766 |
| 19 | response to thyroid hormone (GO:0097066) | 2.83707573 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.82395851 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77655667 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77655667 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 2.77655667 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77655667 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 2.77655667 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77655667 |
| 27 | pinocytosis (GO:0006907) | 2.76028783 |
| 28 | positive regulation of receptor recycling (GO:0001921) | 2.72317479 |
| 29 | localization within membrane (GO:0051668) | 2.72098512 |
| 30 | protein retention in ER lumen (GO:0006621) | 2.71310396 |
| 31 | activation of MAPKKK activity (GO:0000185) | 2.65940471 |
| 32 | glycolipid catabolic process (GO:0019377) | 2.65183871 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64046087 |
| 34 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63865156 |
| 35 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61457058 |
| 36 | regulation of defense response to virus by virus (GO:0050690) | 2.61454673 |
| 37 | amino sugar catabolic process (GO:0046348) | 2.57694905 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 2.56859502 |
| 39 | hypotonic response (GO:0006971) | 2.53203268 |
| 40 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.52451445 |
| 41 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52116670 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 2.50521641 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 2.48667538 |
| 44 | regulation of podosome assembly (GO:0071801) | 2.47071338 |
| 45 | detection of other organism (GO:0098543) | 2.44934812 |
| 46 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44842415 |
| 47 | regulation of superoxide anion generation (GO:0032928) | 2.42492147 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.39779859 |
| 49 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.38312721 |
| 50 | basement membrane organization (GO:0071711) | 2.37998382 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 2.37208390 |
| 52 | detection of bacterium (GO:0016045) | 2.36406347 |
| 53 | positive regulation of extracellular matrix organization (GO:1903055) | 2.35807750 |
| 54 | sodium ion export (GO:0071436) | 2.34709604 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33764012 |
| 56 | negative regulation of cell killing (GO:0031342) | 2.33764012 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 2.33344014 |
| 58 | vesicle coating (GO:0006901) | 2.32067889 |
| 59 | membrane raft organization (GO:0031579) | 2.31285628 |
| 60 | hyaluronan catabolic process (GO:0030214) | 2.31024591 |
| 61 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30682008 |
| 62 | decidualization (GO:0046697) | 2.30048325 |
| 63 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.29169934 |
| 64 | negative regulation of interleukin-12 production (GO:0032695) | 2.28611631 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.27883875 |
| 66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.26674403 |
| 67 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26160432 |
| 68 | detection of molecule of bacterial origin (GO:0032490) | 2.25798583 |
| 69 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.25007461 |
| 70 | modulation by symbiont of host cellular process (GO:0044068) | 2.23939269 |
| 71 | cellular copper ion homeostasis (GO:0006878) | 2.22644108 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.22143984 |
| 73 | regulation of cellular amide metabolic process (GO:0034248) | 2.22043357 |
| 74 | glucose 6-phosphate metabolic process (GO:0051156) | 2.21845420 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.21503542 |
| 76 | regulation of type 2 immune response (GO:0002828) | 2.19997240 |
| 77 | positive regulation of protein dephosphorylation (GO:0035307) | 2.19840732 |
| 78 | protein maturation by protein folding (GO:0022417) | 2.18323458 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.18195815 |
| 80 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.17775159 |
| 81 | germinal center formation (GO:0002467) | 2.16712149 |
| 82 | cell adhesion mediated by integrin (GO:0033627) | 2.15531683 |
| 83 | leukocyte aggregation (GO:0070486) | 2.15089931 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.13658672 |
| 85 | signal complex assembly (GO:0007172) | 2.13506352 |
| 86 | ceramide catabolic process (GO:0046514) | 2.13305536 |
| 87 | cortical actin cytoskeleton organization (GO:0030866) | 2.12687089 |
| 88 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.10660732 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.10033657 |
| 90 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.09924607 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.09038776 |
| 92 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.09017025 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 2.08819531 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.08610289 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.08579966 |
| 96 | positive regulation of leukocyte degranulation (GO:0043302) | 2.07871061 |
| 97 | regulation of macrophage cytokine production (GO:0010935) | 2.06846371 |
| 98 | negative regulation of type 2 immune response (GO:0002829) | 2.06587788 |
| 99 | modulation by virus of host morphology or physiology (GO:0019048) | 2.06301502 |
| 100 | eosinophil chemotaxis (GO:0048245) | 2.06287625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.18580812 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15204822 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.87920366 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.70855244 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69457731 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50705723 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40898384 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38698615 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.35340397 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21748143 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12135757 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11622821 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01494407 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.01208582 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96529996 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90470446 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88239164 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87724234 |
| 19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86645939 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.82927853 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79059541 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76889412 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75808864 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64806666 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63405912 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60118636 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59732342 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58583703 |
| 29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.58508292 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57231506 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55128464 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54617022 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52562266 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.49758077 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49273198 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47973431 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47369291 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41953324 |
| 39 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41664911 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41390670 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41103196 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39423755 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38995402 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.38355046 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36935336 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36460230 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35480048 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34988698 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34717791 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33229119 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31862133 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30845740 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30353774 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29962794 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27843343 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24419602 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23586014 |
| 58 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23416106 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21749716 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21313906 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19725580 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18692619 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18691275 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18196129 |
| 65 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17592545 |
| 66 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17592545 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16972119 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14498764 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13945077 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12892787 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12817863 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11694716 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.11454178 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10480219 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10117692 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09398211 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08538850 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07462196 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07218381 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07170246 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07105185 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06649404 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06614557 |
| 84 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.06424314 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06377095 |
| 86 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05672255 |
| 87 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05577109 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02876251 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02876251 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00385824 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99687722 |
| 92 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.99377702 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99233952 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98416308 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98142025 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97474365 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96870073 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96803312 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95591028 |
| 100 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94310650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.02645507 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.80871909 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.30910975 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.86975060 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.86739740 |
| 6 | MP0005451_abnormal_body_composition | 2.82069309 |
| 7 | MP0006082_CNS_inflammation | 2.69608646 |
| 8 | MP0009840_abnormal_foam_cell | 2.65933924 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.58531703 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.47838114 |
| 11 | MP0003436_decreased_susceptibility_to | 2.42180644 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.22406748 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.13851511 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.13207091 |
| 15 | MP0003453_abnormal_keratinocyte_physiol | 2.08588044 |
| 16 | MP0003329_amyloid_beta_deposits | 2.02424948 |
| 17 | MP0008260_abnormal_autophagy | 2.01616286 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.00826500 |
| 19 | MP0003075_altered_response_to | 1.94151496 |
| 20 | MP0003724_increased_susceptibility_to | 1.93470084 |
| 21 | MP0000604_amyloidosis | 1.88651900 |
| 22 | MP0004947_skin_inflammation | 1.78279155 |
| 23 | MP0000858_altered_metastatic_potential | 1.77922437 |
| 24 | MP0002796_impaired_skin_barrier | 1.77765454 |
| 25 | MP0004510_myositis | 1.77339622 |
| 26 | MP0000343_altered_response_to | 1.76077940 |
| 27 | MP0002419_abnormal_innate_immunity | 1.75201212 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.68991684 |
| 29 | MP0003091_abnormal_cell_migration | 1.68899762 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.61400949 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.55309074 |
| 32 | MP0003279_aneurysm | 1.49904249 |
| 33 | MP0005166_decreased_susceptibility_to | 1.49489556 |
| 34 | MP0003690_abnormal_glial_cell | 1.48074776 |
| 35 | MP0001958_emphysema | 1.46975643 |
| 36 | MP0005025_abnormal_response_to | 1.46627987 |
| 37 | MP0004858_abnormal_nervous_system | 1.46191732 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.45706899 |
| 39 | MP0001542_abnormal_bone_strength | 1.42794855 |
| 40 | MP0004233_abnormal_muscle_weight | 1.42106559 |
| 41 | MP0003828_pulmonary_edema | 1.40627847 |
| 42 | MP0005023_abnormal_wound_healing | 1.37967209 |
| 43 | MP0005409_darkened_coat_color | 1.35943791 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.35760543 |
| 45 | MP0000920_abnormal_myelination | 1.33612307 |
| 46 | MP0009785_altered_susceptibility_to | 1.33242401 |
| 47 | MP0003448_altered_tumor_morphology | 1.30907989 |
| 48 | MP0005275_abnormal_skin_tensile | 1.24259442 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.23060703 |
| 50 | MP0001849_ear_inflammation | 1.19470587 |
| 51 | MP0005501_abnormal_skin_physiology | 1.14421225 |
| 52 | MP0001790_abnormal_immune_system | 1.14345891 |
| 53 | MP0005387_immune_system_phenotype | 1.14345891 |
| 54 | MP0005165_increased_susceptibility_to | 1.10479778 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.10290150 |
| 56 | MP0008004_abnormal_stomach_pH | 1.09416257 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.05430156 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.04310980 |
| 59 | MP0001851_eye_inflammation | 1.00989143 |
| 60 | MP0009278_abnormal_bone_marrow | 1.00735724 |
| 61 | MP0005390_skeleton_phenotype | 1.00250502 |
| 62 | MP0002060_abnormal_skin_morphology | 0.99547129 |
| 63 | MP0003634_abnormal_glial_cell | 0.98385788 |
| 64 | MP0005076_abnormal_cell_differentiation | 0.97793158 |
| 65 | MP0005671_abnormal_response_to | 0.97119007 |
| 66 | MP0002896_abnormal_bone_mineralization | 0.96387454 |
| 67 | MP0000685_abnormal_immune_system | 0.94982797 |
| 68 | MP0000747_muscle_weakness | 0.93985055 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 0.93777252 |
| 70 | MP0001853_heart_inflammation | 0.93516834 |
| 71 | MP0005164_abnormal_response_to | 0.93014529 |
| 72 | MP0002723_abnormal_immune_serum | 0.92290431 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 0.92282595 |
| 74 | MP0001727_abnormal_embryo_implantation | 0.90979986 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.90313485 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.90267669 |
| 77 | MP0008874_decreased_physiological_sensi | 0.89363196 |
| 78 | MP0001915_intracranial_hemorrhage | 0.89125895 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.88758261 |
| 80 | MP0001845_abnormal_inflammatory_respons | 0.88359549 |
| 81 | MP0002420_abnormal_adaptive_immunity | 0.88341492 |
| 82 | MP0001819_abnormal_immune_cell | 0.88288888 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.88063526 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.86715709 |
| 85 | MP0008469_abnormal_protein_level | 0.85003083 |
| 86 | MP0002405_respiratory_system_inflammati | 0.83884564 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.82627641 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.82627641 |
| 89 | MP0000751_myopathy | 0.82609211 |
| 90 | MP0003795_abnormal_bone_structure | 0.81224276 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.81144499 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.79916471 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.76868144 |
| 94 | MP0005621_abnormal_cell_physiology | 0.71746060 |
| 95 | MP0009764_decreased_sensitivity_to | 0.70520595 |
| 96 | MP0004381_abnormal_hair_follicle | 0.69160854 |
| 97 | MP0001800_abnormal_humoral_immune | 0.68886249 |
| 98 | MP0009763_increased_sensitivity_to | 0.67565728 |
| 99 | MP0002971_abnormal_brown_adipose | 0.66564600 |
| 100 | MP0000681_abnormal_thyroid_gland | 0.66498525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.58230917 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.58230917 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.58230917 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.30051318 |
| 5 | Dysostosis multiplex (HP:0000943) | 3.28101472 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.20859506 |
| 7 | Abnormality of macrophages (HP:0004311) | 2.98814661 |
| 8 | Protrusio acetabuli (HP:0003179) | 2.95838119 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 2.93804107 |
| 10 | Axonal loss (HP:0003447) | 2.91000364 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 2.88637569 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 2.88134964 |
| 13 | Loss of speech (HP:0002371) | 2.86865501 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 2.74745063 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.67737580 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.66791247 |
| 17 | Distal lower limb muscle weakness (HP:0009053) | 2.66546980 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64076492 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64076492 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64076492 |
| 21 | Mucopolysacchariduria (HP:0008155) | 2.61818835 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61818835 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 2.61029957 |
| 24 | Premature rupture of membranes (HP:0001788) | 2.43230305 |
| 25 | Purpura (HP:0000979) | 2.38963655 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35903111 |
| 27 | Amyloidosis (HP:0011034) | 2.33731031 |
| 28 | Apathy (HP:0000741) | 2.33359488 |
| 29 | Diminished motivation (HP:0000745) | 2.32527454 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29822718 |
| 31 | Upper limb amyotrophy (HP:0009129) | 2.29330766 |
| 32 | Distal upper limb amyotrophy (HP:0007149) | 2.29330766 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 2.27905943 |
| 34 | Increased IgE level (HP:0003212) | 2.25600343 |
| 35 | Neuronal loss in central nervous system (HP:0002529) | 2.25276284 |
| 36 | Nuclear cataract (HP:0100018) | 2.24066200 |
| 37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21380966 |
| 38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19101105 |
| 39 | Achilles tendon contracture (HP:0001771) | 2.18110430 |
| 40 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.15676361 |
| 41 | Increased connective tissue (HP:0009025) | 2.11643508 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.11030351 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.06465002 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.06418318 |
| 45 | Hyperparathyroidism (HP:0000843) | 2.06339972 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.02830037 |
| 47 | Osteolytic defects of the hand bones (HP:0009699) | 2.01464237 |
| 48 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01464237 |
| 49 | J-shaped sella turcica (HP:0002680) | 2.00605856 |
| 50 | Hand muscle atrophy (HP:0009130) | 1.98374557 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 1.96602426 |
| 52 | Spinal rigidity (HP:0003306) | 1.93930700 |
| 53 | Cerebral aneurysm (HP:0004944) | 1.92857784 |
| 54 | Vascular tortuosity (HP:0004948) | 1.88223064 |
| 55 | Recurrent abscess formation (HP:0002722) | 1.87357960 |
| 56 | Peripheral hypomyelination (HP:0007182) | 1.86501805 |
| 57 | Mutism (HP:0002300) | 1.86197802 |
| 58 | Bone pain (HP:0002653) | 1.83645029 |
| 59 | Termporal pattern (HP:0011008) | 1.82175653 |
| 60 | Insidious onset (HP:0003587) | 1.82175653 |
| 61 | Spondylolisthesis (HP:0003302) | 1.80857225 |
| 62 | Hypercortisolism (HP:0001578) | 1.76122391 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75420571 |
| 64 | Recurrent bacterial skin infections (HP:0005406) | 1.75368180 |
| 65 | Arterial tortuosity (HP:0005116) | 1.73086814 |
| 66 | Myocardial infarction (HP:0001658) | 1.71946250 |
| 67 | Thin bony cortex (HP:0002753) | 1.70837937 |
| 68 | Disinhibition (HP:0000734) | 1.70654500 |
| 69 | Orchitis (HP:0100796) | 1.70143526 |
| 70 | Muscle fiber splitting (HP:0003555) | 1.69340945 |
| 71 | Lower limb amyotrophy (HP:0007210) | 1.69200833 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68242484 |
| 73 | Petechiae (HP:0000967) | 1.67911656 |
| 74 | Generalized amyotrophy (HP:0003700) | 1.67729381 |
| 75 | Myositis (HP:0100614) | 1.66973329 |
| 76 | Hyperacusis (HP:0010780) | 1.66672044 |
| 77 | Polycythemia (HP:0001901) | 1.65594937 |
| 78 | Hepatosplenomegaly (HP:0001433) | 1.65195152 |
| 79 | Cervical subluxation (HP:0003308) | 1.62145058 |
| 80 | Atrophic scars (HP:0001075) | 1.61458235 |
| 81 | Growth hormone excess (HP:0000845) | 1.61182838 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 1.60283779 |
| 83 | Wormian bones (HP:0002645) | 1.60001062 |
| 84 | Rapidly progressive (HP:0003678) | 1.59137648 |
| 85 | Exercise-induced myalgia (HP:0003738) | 1.58766265 |
| 86 | Difficulty climbing stairs (HP:0003551) | 1.58729915 |
| 87 | Mitral stenosis (HP:0001718) | 1.58305989 |
| 88 | Spontaneous hematomas (HP:0007420) | 1.57877717 |
| 89 | Dementia (HP:0000726) | 1.57514656 |
| 90 | Back pain (HP:0003418) | 1.57323241 |
| 91 | Upper motor neuron abnormality (HP:0002127) | 1.56680465 |
| 92 | Pathologic fracture (HP:0002756) | 1.56660073 |
| 93 | Hyporeflexia of lower limbs (HP:0002600) | 1.56591705 |
| 94 | Deep venous thrombosis (HP:0002625) | 1.56312037 |
| 95 | Slow saccadic eye movements (HP:0000514) | 1.56310895 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.55602985 |
| 97 | Peritonitis (HP:0002586) | 1.54308999 |
| 98 | Broad face (HP:0000283) | 1.54220198 |
| 99 | Abnormality of complement system (HP:0005339) | 1.53944705 |
| 100 | Gingivitis (HP:0000230) | 1.53038821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.13241135 |
| 2 | TAOK2 | 3.07025359 |
| 3 | TAOK1 | 2.84294106 |
| 4 | MAP3K3 | 2.74904364 |
| 5 | TRIB3 | 2.67717369 |
| 6 | PRPF4B | 2.63066294 |
| 7 | TESK1 | 2.61654454 |
| 8 | RIPK1 | 2.55575646 |
| 9 | IRAK3 | 2.44720910 |
| 10 | MAP2K3 | 2.26106296 |
| 11 | MAP3K11 | 2.16812438 |
| 12 | EPHB1 | 2.13701084 |
| 13 | ARAF | 2.05049230 |
| 14 | MAP3K13 | 1.71951914 |
| 15 | ICK | 1.70436564 |
| 16 | RIPK4 | 1.65962295 |
| 17 | MOS | 1.61931638 |
| 18 | TESK2 | 1.61069929 |
| 19 | SIK1 | 1.55116635 |
| 20 | SIK3 | 1.54222338 |
| 21 | CDK12 | 1.51088045 |
| 22 | MAP3K1 | 1.47652406 |
| 23 | DDR2 | 1.44917344 |
| 24 | KSR2 | 1.40600326 |
| 25 | NME2 | 1.40148356 |
| 26 | MAP3K14 | 1.35119817 |
| 27 | TBK1 | 1.31085319 |
| 28 | PDGFRA | 1.29730930 |
| 29 | LIMK1 | 1.20859906 |
| 30 | CSK | 1.20056234 |
| 31 | PAK4 | 1.19042219 |
| 32 | JAK3 | 1.17555883 |
| 33 | PIM2 | 1.16808209 |
| 34 | ZAP70 | 1.16124710 |
| 35 | TTN | 1.15902789 |
| 36 | SCYL2 | 1.14679885 |
| 37 | ABL2 | 1.14517401 |
| 38 | LATS2 | 1.13638769 |
| 39 | TYK2 | 1.12429215 |
| 40 | SMG1 | 1.11324432 |
| 41 | NTRK1 | 1.11059240 |
| 42 | FGFR4 | 1.06569970 |
| 43 | PTK2 | 1.03475258 |
| 44 | CDC42BPA | 1.00187144 |
| 45 | EPHA2 | 0.93693570 |
| 46 | TGFBR2 | 0.86811473 |
| 47 | PRKD2 | 0.86717350 |
| 48 | PDPK1 | 0.86010347 |
| 49 | LRRK2 | 0.83425575 |
| 50 | MAP3K9 | 0.81698217 |
| 51 | STK10 | 0.78292948 |
| 52 | PTK6 | 0.78056548 |
| 53 | PRKD3 | 0.77690795 |
| 54 | MAP3K5 | 0.76865539 |
| 55 | BLK | 0.74872869 |
| 56 | JAK1 | 0.70332596 |
| 57 | FGR | 0.70054348 |
| 58 | PAK2 | 0.68671555 |
| 59 | DMPK | 0.68441211 |
| 60 | MAP3K8 | 0.67530790 |
| 61 | MARK2 | 0.65483613 |
| 62 | EPHA3 | 0.62909710 |
| 63 | MAP3K6 | 0.62304957 |
| 64 | IRAK4 | 0.61450200 |
| 65 | LMTK2 | 0.60835160 |
| 66 | STK38 | 0.59920073 |
| 67 | RPS6KA2 | 0.59112048 |
| 68 | ROCK2 | 0.57967645 |
| 69 | MAP3K2 | 0.57743508 |
| 70 | PKN2 | 0.57227840 |
| 71 | MATK | 0.55778515 |
| 72 | FES | 0.54461033 |
| 73 | MYLK | 0.52599911 |
| 74 | PDK1 | 0.50881440 |
| 75 | GRK7 | 0.50810610 |
| 76 | PDGFRB | 0.49692157 |
| 77 | MTOR | 0.47696901 |
| 78 | TYRO3 | 0.47643372 |
| 79 | MAPK12 | 0.47252728 |
| 80 | MAP3K12 | 0.46607205 |
| 81 | CDK6 | 0.45491003 |
| 82 | SIK2 | 0.44991533 |
| 83 | PAK6 | 0.44754329 |
| 84 | MAP4K1 | 0.42893517 |
| 85 | JAK2 | 0.42266275 |
| 86 | BMX | 0.41632993 |
| 87 | BRAF | 0.40221379 |
| 88 | MST1R | 0.39992567 |
| 89 | NEK9 | 0.39852468 |
| 90 | CSF1R | 0.39480656 |
| 91 | CDK14 | 0.39333168 |
| 92 | MAPK7 | 0.38779749 |
| 93 | KSR1 | 0.37853013 |
| 94 | RAF1 | 0.36896552 |
| 95 | PRKD1 | 0.36860729 |
| 96 | HIPK2 | 0.36818969 |
| 97 | FER | 0.34638652 |
| 98 | YES1 | 0.34145395 |
| 99 | PDK2 | 0.34010626 |
| 100 | PRKCH | 0.33970202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.88815604 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.65818206 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 2.27679923 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.16361228 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86413219 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70641245 |
| 7 | Prion diseases_Homo sapiens_hsa05020 | 1.64962945 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.57111151 |
| 9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.51605984 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50882449 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50268827 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46663230 |
| 13 | * Phagosome_Homo sapiens_hsa04145 | 1.42971858 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.40723907 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36953460 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.35001145 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.33278864 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.32249726 |
| 19 | * Salmonella infection_Homo sapiens_hsa05132 | 1.32172410 |
| 20 | * Amoebiasis_Homo sapiens_hsa05146 | 1.31803702 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30982721 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.23604963 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22392847 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21973860 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.20876620 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19633705 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18333989 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17936581 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17671631 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17572533 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17177807 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16408161 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15603475 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13468686 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13262493 |
| 36 | * Endocytosis_Homo sapiens_hsa04144 | 1.12732907 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12545951 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11643473 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08328883 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05012676 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03984233 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01484361 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.00536345 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00504149 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.00321108 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.99073758 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.97008307 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96486615 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95797530 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95763481 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91506529 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91283380 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90886962 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90860119 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89810045 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85457457 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83963255 |
| 58 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83083152 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.82853494 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82795829 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82127204 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81522278 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.81395281 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80870478 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.80606551 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77093495 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76439319 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75280428 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74806709 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.73335702 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71512402 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70169663 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69624162 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.69428975 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69426711 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68876657 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68130055 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67764931 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67614363 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67410450 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65618753 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.64766435 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64158558 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.62743618 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61609066 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.61372528 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61364581 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60462877 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.60359783 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.59284162 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57319108 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57082217 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55599555 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53759626 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53302046 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52390797 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52388098 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51635988 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51625651 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49231207 |

